Suzhou Zelgen Biopharmaceuticals Co Ltd (688266) — Free Cash Flow Generation Index

Latest as of September 2025: -96.08x

Suzhou Zelgen Biopharmaceuticals Co Ltd (688266) has a Free Cash Flow Generation Index of -96.08x as of September 2025. Free cash flow of CN¥-52.24 Million represents -96% of operating cash flow (CN¥543.69K). See 688266 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

-96.08x

Free Cash Flow / Operating CF

Free Cash Flow

CN¥-52.24 Million

CNY

Operating Cash Flow

CN¥543.69K

CNY

Capital Expenditures

CN¥52.78 Million

CNY

Suzhou Zelgen Biopharmaceuticals Co Ltd Free Cash Flow Generation Index (2024–2024)

Historical FCF Generation Index trend for Suzhou Zelgen Biopharmaceuticals Co Ltd across 1 annual periods. Explore Suzhou Zelgen Biopharmaceuticals Co Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Suzhou Zelgen Biopharmaceuticals Co Ltd (2024–2024)

Year-by-year Free Cash Flow Generation Index for Suzhou Zelgen Biopharmaceuticals Co Ltd. For the full company profile including market capitalisation, see Suzhou Zelgen Biopharmaceuticals Co Ltd (688266) total market value.

Year	FCG Index	Free Cash Flow (CNY)	Operating CF	Capital Expenditures	YoY Change
2024	-1.50x	CN¥-57.49 Million	CN¥38.20 Million	CN¥95.69 Million	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).